Educational guide
Peptide Therapeutics Forum 2023 - Swiss Chemical Society
Peptide Therapeutics Forum 2023 Welcome to the website of the Peptide Therapeutics Forum 2023, which took plae on September 4-5, 2023 at the Zentrum für Lehre und Forschung of University Hospital Basel. Similar to previous events in the framework of Basel Life
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Peptide Therapeutics Forum 2023
Welcome to the website of the Peptide Therapeutics Forum 2023, which took plae on September 4-5, 2023 at the Zentrum für Lehre und Forschung of University Hospital Basel.
Similar to previous events in the framework of Basel Life, presentations highlighted important new insights regarding the drug discovery of peptides including examples for successful development candidates. The forum disseminated information on latest news in the broad field of therapeutic peptides and enables networking of interested parties from academia and industries.
Invited Speakers:
Prof. Markus Kaiser, University of Essen (DEU)
Prof. Kim Lewis, Northeastern University (USA)
Prof. Yu-Shan Lin, Tufts University, Medford (USA)
Dr. Hans Maric, University of Würzburg (DEU)
Prof. Christian Ottmann, Eindhoven University of Technology (NLD)
Prof. Stephan Pless, University of Copenhagen (DNK)
Prof. Ali Tavassoli, University of Southampton (UK)
Prof. Paramjit Arora, University of New York (USA)
Dr. René Thürmer, Federal Institute for Drugs and Medical Devices, Bonn (DEU)
Dr. Virginia Castillo, Peptomyc, Barcelona (ESP)
Dr. Gao Shang, Merck & Co Inc, New York (USA)
Dr. Frank Osterkamp, 3B Pharmaceuticals Berlin (DEU)
Prof. Krishna Kumar, Tufts University, Medford (USA)
Organizing Committee
Prof. Melpomeni Fani, University of Basel, Radiopharmaceutical Chemistry, Clinic of Radiology and Nuclear Medicine
Prof. Roderich Süssmuth, Technische Universität Berlin, Department of Chemistry
Dr. Thomas Vorherr, Technische Universität Berlin, Department of Chemistry
Prof. Nina Hartrampf, University of Zurich
Best Short Talk and Best Poster Prizes
The two best short talks were honored with the Helvetica Best Short Talk award:
- Mirja Harms, Ulm University Medical Center
«Preclinical development of the endogenous CXCR4 antagonist EPI-X4 for therapy of cancer and inflammatory diseases»
- Héloïse Bürgisser, University of Zurich
«Chemical synthesis of c-Myc transactivation domain using a synthesis/solubility tag»
Information / Warning to be careful
To all participants, speakers and invited guests:
Please note that requests for any organizational issues will only be made by OC members of the event or the SCS Head Office (...@scg.ch). We do not collaborate with travel agencies that claim to book travel and accommodation on our behalf. In case of any uncertainty, please contact and make sure that there is no fraudulent activity going on.
Symposium Sekretariat
SCS Head Office
+41 31 306 92 92